newsfilter
← Latest News
PR Newswire·

AbbVie to Acquire Apogee Therapeutics, Deepening Immunology Portfolio

AbbVie (NYSE: ABBV) and Apogee Therapeutics (NASDAQ: APGE) ("Apogee") today announced they have entered into a definitive agreement under which...